Skip to main content

Table 2 Demographic and clinical characteristics of enrolled patients and their association with history of anti-tuberculosis treatment

From: Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study

 Retreatment
(n = 697)
New
(n = 3720)
All
(n = 4417)
OR (95% CI)p-valueaOR (95% CI)p-value
Age (years)
 15–3468 (9.8%)666 (17.9%)734 (16.6%)    
 35–59275 (39.5%)1318 (35.4%)1593 (36.1%)2.04 (1.54–2.71)0.0001.85 (1.39–2.47)0.000
  ≥ 60354 (50.85)1736 (46.7%)2090 (47.3%)2.00 (1.52–2.63)0.0001.94 (1.47–2.56)0.000
Male gender495 (71.0%)2130 (57.3%)2625 (59.4%)1.83 (1.53–2.18)0.0001.75 (1.46–2.09)0.000
Pulmonary involvement669 (96.0%)3465 (93.1%)4134 (93.6%)1.76 (1.18–2.62)0.0061.49 (0.99–2.23)0.056
Drug-resistant TB174 (25.0%)510 (13.7%)684 (15.5%)2.09 (1.72–2.55)0.0002.13 (1.74–2.59)0.000
Notification year
 2015193 (27.7%)1023 (27.5%)1216 (27.5%)    
 2016163 (23.4%)1023 (27.5%)1186 (26.9%)0.85 (0.67–1.06)0.143  
 2017160 (23.0%)821 (22.1%)981 (22.2%)1.03 (0.82–1.30)0.781  
 2018181 (26.0%)853 (22.9%)1034 (23.4%)1.13 (0.90–1.41)0.300  
  1. OR odds ratio, CI confidence interval, aOR adjusted odds ratio, TB tuberculosis